6564 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6564)
  2. Epidemiology and Biostatistics (6564)
  3. Department of Medicine (3848)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2487)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1977)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2394)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6564)
  2. Epidemiology and Biostatistics (6564)
  3. Department of Medicine (3848)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2487)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (464)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (118)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6564)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Jarnagin, W. R.; Brennan, M. F.; Winston, C.; Tang, L. H.; Capanu, M.; Schattner, M.; Chen, L. Y.; DeMatteo, R. P.; DiMaio, C. J.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term response to sunitinib for metastatic renal cell carcinoma (mRCC) patients treated on clinical trials at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Molina, A. M.; Jia, X.; Ginsberg, M. S.; Velasco, S.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)
    Meeting Abstract

    Morris, P. G.; Fazio, M.; Jhaveri, K. L.; Serna-Tamayo, C.; Eaton, A.; Patil, S.; Ulaner, G.; Howard, J.; Larson, S. M.; Hudis, C.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium
    Meeting Abstract

    Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Al-Ahmadie, H.; Ostrovnaya, I.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Is PET scan conversion from positive to negative a prognostic indicator for patients receiving therapy for unresectable liver metastases from colorectal carcinoma (CRC)?
    Meeting Abstract

    Maddox, G. J.; Chou, J. F.; Capanu, M.; Patel, D.; D'Angelica, M. I.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Does the underlying etiology of HCC effect outcome? A single-institution analysis
    Meeting Abstract

    Ma, J.; Capanu, M.; O'Reilly, E. M.; Kemeny, N. E.; Ang, C.; Gansukh, B.; Kelsen, D. P.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical outcomes in patients age 40 or younger at diagnosis of synchronous metastatic colorectal cancer: A 20-year experience at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Lowery, M. A.; Gallagher, D. J.; Capanu, M.; Chou, J. F.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Jhaveri, K. L.; Patil, S.; Khasraw, M.; Bhatia, J.; Stadler, Z. K.; Kauff, N. D.; Hudis, C.; Offit, K.; Robson, M. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?
    Meeting Abstract

    Kemeny, N. E.; Schwartz, L. H.; Gonen, M.; Yopp, A. C.; D'Angelica, M. I.; Fong, Y.; Haviland, D.; Gewirtz, A. N.; Allen, P. J.; Jarnagin, W. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save